BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 19633001)

  • 1. Evaluation of wild-type MIC distributions as a tool for determination of clinical breakpoints for Mycobacterium tuberculosis.
    Schön T; Juréen P; Giske CG; Chryssanthou E; Sturegård E; Werngren J; Kahlmeter G; Hoffner SE; Angeby KA
    J Antimicrob Chemother; 2009 Oct; 64(4):786-93. PubMed ID: 19633001
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wild-type MIC distributions of four fluoroquinolones active against Mycobacterium tuberculosis in relation to current critical concentrations and available pharmacokinetic and pharmacodynamic data.
    Angeby KA; Jureen P; Giske CG; Chryssanthou E; Sturegård E; Nordvall M; Johansson AG; Werngren J; Kahlmeter G; Hoffner SE; Schön T
    J Antimicrob Chemother; 2010 May; 65(5):946-52. PubMed ID: 20332195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of correlation between embB mutation and ethambutol MIC in Mycobacterium tuberculosis clinical isolates from China.
    Shi R; Zhang J; Otomo K; Zhang G; Sugawara I
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4515-7. PubMed ID: 17846128
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The resistance rates of Mycobacterium tuberculosis strains to antituberculosis drugs: evaluation of two years' data in Aegean region, Turkey].
    Güneri S; Unsal I; Oztop A; Erkut M; Avkan Oğuz V; Ozgü A; Cakmak R
    Mikrobiyol Bul; 2004 Jul; 38(3):203-12. PubMed ID: 15490839
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Reference Laboratory Network: five rounds of proficiency testing, 1994-1998.
    Laszlo A; Rahman M; Espinal M; Raviglione M;
    Int J Tuberc Lung Dis; 2002 Sep; 6(9):748-56. PubMed ID: 12234129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of linezolid in combination with isoniazid and rifampicin against multidrug resistant Mycobacterium tuberculosis clinical isolates].
    Coban AY; Bilgin K; Uzun M; Durupinar B
    Mikrobiyol Bul; 2009 Apr; 43(2):293-7. PubMed ID: 19621615
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis: a study using external quality assessment strains].
    Kobayashi I; Abe C; Mitarai S
    Kekkaku; 2006 Feb; 81(2):57-62. PubMed ID: 16529006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequency of embB codon 306 mutations in ethambutol-susceptible and -resistant clinical Mycobacterium tuberculosis isolates in Kuwait.
    Ahmad S; Jaber AA; Mokaddas E
    Tuberculosis (Edinb); 2007 Mar; 87(2):123-9. PubMed ID: 17289435
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wild-type MIC distributions for aminoglycoside and cyclic polypeptide antibiotics used for treatment of Mycobacterium tuberculosis infections.
    Juréen P; Angeby K; Sturegård E; Chryssanthou E; Giske CG; Werngren J; Nordvall M; Johansson A; Kahlmeter G; Hoffner S; Schön T
    J Clin Microbiol; 2010 May; 48(5):1853-8. PubMed ID: 20237102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous ethambutol & isoniazid resistance in clinical isolates of Mycobacterium tuberculosis.
    Gupta P; Jadaun GP; Das R; Gupta UD; Srivastava K; Chauhan A; Sharma VD; Chauhan DS; Katoch VM
    Indian J Med Res; 2006 Feb; 123(2):125-30. PubMed ID: 16575110
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antimicrobial susceptibility testing for Mycobacterium tuberculosis by measuring mycobacterial adenosine triphosphate].
    Yamazaki T; Sato N; Yamashita K; Okazawa Y; Miyao H; Tanno K
    Rinsho Byori; 1999 Feb; 47(2):170-5. PubMed ID: 10097635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synergistic effect of two combinations of antituberculous drugs against Mycobacterium tuberculosis.
    Rey-Jurado E; Tudó G; Martínez JA; González-Martín J
    Tuberculosis (Edinb); 2012 May; 92(3):260-3. PubMed ID: 22342247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Susceptibility testing of Mycobacterium tuberculosis: comparison of the BACTEC TB-460 method and flow cytometric assay with the proportion method.
    DeCoster DJ; Vena RM; Callister SM; Schell RF
    Clin Microbiol Infect; 2005 May; 11(5):372-8. PubMed ID: 15819863
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid mycobacteria drug susceptibility testing using Gel Microdrop (GMD) Growth Assay and flow cytometry.
    Akselband Y; Cabral C; Shapiro DS; McGrath P
    J Microbiol Methods; 2005 Aug; 62(2):181-97. PubMed ID: 16009276
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Blood agar for susceptibility testing of Mycobacterium tuberculosis against first-line drugs.
    Coban AY; Cihan CC; Bilgin K; Uzun M; Akgunes A; Cetinkaya E; Durupinar B
    Int J Tuberc Lung Dis; 2006 Apr; 10(4):450-3. PubMed ID: 16602412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Resistance rates of Mycobacterium tuberculosis complex strains isolated from clinical specimens].
    Aydın F; Kaklıkkaya N; Bayramoğlu G; Ozkul G; Buruk K; Dinç U; Köse T; Dede R
    Mikrobiyol Bul; 2011 Jan; 45(1):36-42. PubMed ID: 21341157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug susceptibility testing of Mycobacterium tuberculosis complex by use of a high-throughput, reproducible, absolute concentration method.
    van Klingeren B; Dessens-Kroon M; van der Laan T; Kremer K; van Soolingen D
    J Clin Microbiol; 2007 Aug; 45(8):2662-8. PubMed ID: 17537932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Evaluation of the BACTEC MGIT 960 system for drug susceptibility testing of Mycobacterium tuberculosis isolates compared with the proportion method on solid media].
    Abe C; Aono A; Hirano K
    Kekkaku; 2001 Oct; 76(10):657-62. PubMed ID: 11712386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid and simple MTT method for rifampicin and isoniazid susceptibility testing of Mycobacterium tuberculosis.
    Foongladda S; Roengsanthia D; Arjrattanakool W; Chuchottaworn C; Chaiprasert A; Franzblau SG
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1118-22. PubMed ID: 12546122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of a modified antimycobacterial susceptibility test using Middlebrook 7H10 agar containing 2,3-diphenyl-5-thienyl-(2)-tetrazolium chloride.
    Lee S; Kong DH; Yun SH; Lee KR; Lee KP; Franzblau SG; Lee EY; Chang CL
    J Microbiol Methods; 2006 Sep; 66(3):548-51. PubMed ID: 16563534
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.